Rheumatoid arthritis

Validation of rheumatoid arthritis low inflammatory activity: a novel clinical target quantifying inflammatory disease activity

Ann Rheum DisPublished Validation study using data from 3 clinical trials and a large real-world study

Authors' conclusion

More patients achieved RALI than traditional remission with similar or lower rates of radiographic progression as well as low rates of high-risk characteristics and adverse long-term outcomes. These results support RALI as a point-of-care clinical target to inform management.

Study context

Population
Patients with rheumatoid arthritis in 3 clinical trials and the Veterans Affairs Rheumatoid Arthritis (VARA) RegistryParticipants from 3 clinical trials and the VARA Registry · 3 clinical trials 960 · VARA Registry 3,423
Comparison
RALI compared with traditional clinical remission
Outcome
Thresholds for RALI
Methodological detailsreceiver-operating-characteristic analyses, descriptive statistics, Cox regression
  • Receiver-operating-characteristic analyses
  • Descriptive statistics
  • Cox regression

Performance

As reported in the abstract

M-DAS28

<1.4

Modified Simplified Disease Activity Index

≤3

Modified Clinical Disease Activity Index

≤2

Further findings

Frequency in VARA

  • Frequency in VARA: M-DAS28 RALI vs DAS28 remission

Number in RALI vs in remission by traditional scores (3 datasets)

A greater number were in RALI compared with the number in remission by traditional scores

Radiographic progression

RALI was similarly predictive of radiographic progression compared with remission defined by traditional scores

Characteristics of those in RALI but with high traditional scores

Higher rates of comorbidity (eg, anxiety and depression) and lower rates of seropositivity and erosive disease

Cardiovascular disease and death

RALI was a stronger predictor of cardiovascular disease and death than traditional scores

Original publication

Validation of rheumatoid arthritis low inflammatory activity: a novel clinical target quantifying inflammatory disease activity. Ann Rheum Dis. Published 12 November 2026. doi:10.1016/j.ard.2026.10.3165

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.